Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges.
The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.
